Abstract
Drug-coated balloons have emerged as a promising therapeutic option in the treatment of cardiovascular disease. This review article provides an overview of the concept of drug-coated balloons and their clinical applications in both de novo and treated coronary artery disease. A summary of key clinical trials and registry studies evaluating drug-coated balloons is presented for reference. Overall, this article aims to provide clinicians and researchers with a comprehensive understanding of the current state of drug-coated balloon technology and its implications in clinical practice.
| Original language | English |
|---|---|
| Pages (from-to) | 84-95 |
| Number of pages | 12 |
| Journal | Trends in Cardiovascular Medicine |
| Volume | 35 |
| Issue number | 2 |
| Early online date | 5 Sept 2024 |
| DOIs | |
| Publication status | Published - Feb 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- AMI
- CAD
- Coronary Drug-Coated Balloons
- CTO
- DCB
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver